103 related articles for article (PubMed ID: 10072247)
1. Relation of fibrinolytic potentiation by estrogen to coagulation pathway activation in postmenopausal women.
Koh KK; Horne MK; Csako G; Waclawiw MA; Cannon RO
Am J Cardiol; 1999 Feb; 83(3):466-9, A10. PubMed ID: 10072247
[TBL] [Abstract][Full Text] [Related]
2. Changes in coagulation factors and fibrinolytic components of postmenopausal women receiving continuous hormone replacement therapy.
Nozaki M; Ogata R; Koera K; Hashimoto K; Nakano H
Climacteric; 1999 Jun; 2(2):124-30. PubMed ID: 11910665
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women.
Brown NJ; Abbas A; Byrne D; Schoenhard JA; Vaughan DE
Circulation; 2002 Jan; 105(3):304-9. PubMed ID: 11804984
[TBL] [Abstract][Full Text] [Related]
4. Effects of hormone replacement therapy on the circadian pattern of atherothrombotic risk factors.
Katz RJ; Hsia J; Walker P; Jacobs H; Kessler C
Am J Cardiol; 1996 Oct; 78(8):876-80. PubMed ID: 8888658
[TBL] [Abstract][Full Text] [Related]
5. Effects of hormone replacement therapy on blood coagulation and fibrinolysis in hypertensive and normotensive postmenopausal women.
Sumino H; Ichikawa S; Sawada Y; Sakamoto H; Kumakura H; Takayama Y; Sakamaki T; Kurabayashi M
Thromb Res; 2005; 115(5):359-66. PubMed ID: 15733968
[TBL] [Abstract][Full Text] [Related]
6. Effect of pulsed estrogen therapy on hemostatic markers in comparison with oral estrogen regimen in postmenopausal women.
Basurto L; Saucedo R; Zárate A; Martínez C; Gaminio E; Reyes E; Hernandez M
Gynecol Obstet Invest; 2006; 61(2):61-4. PubMed ID: 16192735
[TBL] [Abstract][Full Text] [Related]
7. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women.
Koh KK; Mincemoyer R; Bui MN; Csako G; Pucino F; Guetta V; Waclawiw M; Cannon RO
N Engl J Med; 1997 Mar; 336(10):683-90. PubMed ID: 9041098
[TBL] [Abstract][Full Text] [Related]
8. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study.
Gebara OC; Mittleman MA; Sutherland P; Lipinska I; Matheney T; Xu P; Welty FK; Wilson PW; Levy D; Muller JE
Circulation; 1995 Apr; 91(7):1952-8. PubMed ID: 7895352
[TBL] [Abstract][Full Text] [Related]
9. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA
Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
[TBL] [Abstract][Full Text] [Related]
10. The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of literature.
Douketis JD; Gordon M; Johnston M; Julian JA; Adachi JR; Ginsberg JS
Thromb Res; 2000 Jul; 99(1):25-34. PubMed ID: 11012376
[TBL] [Abstract][Full Text] [Related]
11. Prospective randomized study of effects of unopposed estrogen replacement therapy on markers of coagulation and inflammation in postmenopausal women.
Luyer MD; Khosla S; Owen WG; Miller VM
J Clin Endocrinol Metab; 2001 Aug; 86(8):3629-34. PubMed ID: 11502788
[TBL] [Abstract][Full Text] [Related]
12. [Estrogen replacement in postmenopause, blood coagulation and fibrinolysis: comparison of a new kind of transdermal estradiol treatment with oral therapy with conjugated estrogens].
Winkler UH; Krämer R; Kwee B; Schindler AE
Zentralbl Gynakol; 1995; 117(10):540-8. PubMed ID: 7491837
[TBL] [Abstract][Full Text] [Related]
13. The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal status.
Gilabert J; Estellés A; Cano A; España F; Barrachina R; Grancha S; Aznar J; Tortajada M
Am J Obstet Gynecol; 1995 Dec; 173(6):1849-54. PubMed ID: 8610774
[TBL] [Abstract][Full Text] [Related]
14. Estrogen treatment improves arterial distensibility, fibrinolysis, and metabolic profile in postmenopausal women with type 2 diabetes mellitus.
Sztejnsznajd C; Silva ME; Nussbacher A; Gebara OE; D'Amico EA; Rocha DM; da Rocha TR; Santos RF; Wajngarten M; Fukui RT; Correia MR; Wajchenberg BL; Ursich MJ
Metabolism; 2006 Jul; 55(7):953-9. PubMed ID: 16784970
[TBL] [Abstract][Full Text] [Related]
15. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
16. Raloxifene lowers serum lipoprotein(A) in healthy postmenopausal women: a randomized, double-blind, placebo-controlled comparison with conjugated equine estrogens.
Mijatovic V; van der Mooren MJ; Kenemans P; de Valk-de Roo GW; Netelenbos C
Menopause; 1999; 6(2):134-7. PubMed ID: 10374220
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of droloxifene, a new selective estrogen receptor modulator, in healthy postmenopausal women.
Herrington DM; Pusser BE; Riley WA; Thuren TY; Brosnihan KB; Brinton EA; MacLean DB
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1606-12. PubMed ID: 10845879
[TBL] [Abstract][Full Text] [Related]
18. Effect of estrogen-progestin hormonal replacement therapy on blood coagulation and fibrinolysis in postmenopausal women.
Bonduki CE; Lourenço DM; Motta EL; Soares JM; Haidar MA; Baracat EC
Clinics (Sao Paulo); 2007 Oct; 62(5):553-60. PubMed ID: 17952314
[TBL] [Abstract][Full Text] [Related]
19. Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal women.
Madsen JS; Kristensen SR; Gram J; Bladbjerg EM; Henriksen FL; Gram J; Christensen K; Jespersen J
J Thromb Haemost; 2003 Sep; 1(9):1984-91. PubMed ID: 12941041
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of the ultra-low dose and standard estrogen plus dydrogesterone therapy on thrombin generation and fibrinolysis in postmenopausal women.
Piróg M; Jach R; Kacalska-Janssen O
Acta Obstet Gynecol Scand; 2017 Dec; 96(12):1438-1445. PubMed ID: 28981954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
